Drawing for SCANLY

USPTO serial 90289003

SCANLY

Reviewed by CopyMark Law Group

Reg. 7892096Status 700Registered
Filing date
Status date
Registration date
Aug 12, 2025
Examiner
MORRIS, KRISTINA KLOIBER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SCANLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Manuel Valcarcel, Esq.

Manuel Valcarcel, Esq. GREENBERG TRAURIG, P.A.333 S.E. 2ND AVENUE, 44TH FLOORMIAMI, FL 33131United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, apparatus, instruments and equipment for the viewing, detection, diagnosis, management and treatment of retinal diseases, namely, macular degeneration, diabetic macular edema (DME), retinal vein occlusion(RVO), high Myopia and Glaucoma; medical devices, apparatus, instruments, and equipment for the viewing, detection, diagnosis, management and treatment of macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma and other eye conditions and diseases; optical coherence tomography devices and equipment for home use; medical devices, apparatus, instruments, and equipment for monitoring progression of eye conditions and diseases and in particular for use in the detection and characterization of patients with age-related macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma; and parts and fittings for all the aforementioned goodsACTIVEJun 17, 2024
042Software as a service (SAAS) services, namely, hosting a cloud-based platform that allows for uploading and analyzing test results; Software as a service (SAAS) services featuring non-downloadable software and proprietary algorithms for analyzing optical coherence tomography imaging; Providing online, non-downloadable software allowing for interactive communications and exchange of information between healthcare professionals and patients; Providing online, non-downloadable software for healthcare professionals to receive and provide patient-specific information; Providing online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical information; Providing a website featuring online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical informationACTIVEJun 21, 2024
044Medical services, namely, vision care services and eye care services; provision of optical medical services, ophthalmic services, and ophthalmic diagnostic services; patient rehabilitation care services; medical consultations in the nature of provision of medical second opinions; information, advisory and consultancy services relating to all of the aforementioned services; providing information relating to ophthalmic services and ophthalmic diagnostic services; providing a website and online computer database featuring vision care and eye care, optical and ophthalmic medical information for use by medical and healthcare service providers and patients; providing patient-specific medical information to healthcare professionalsACTIVEJun 17, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 12, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 18, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 17, 2025DOCKASSIGNED TO EXAMINER—
Jan 22, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 22, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 7, 2024IUAFUSE AMENDMENT FILED—
Nov 7, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 21, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2024EX5GSOU EXTENSION 5 GRANTED—
May 20, 2024EXT5SOU EXTENSION 5 FILED—
May 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 22, 2023EX4GSOU EXTENSION 4 GRANTED—
Nov 22, 2023EXT4SOU EXTENSION 4 FILED—
Nov 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 9, 2023EX3GSOU EXTENSION 3 GRANTED—
May 9, 2023EXT3SOU EXTENSION 3 FILED—
May 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 14, 2022EX2GSOU EXTENSION 2 GRANTED—
Nov 14, 2022EXT2SOU EXTENSION 2 FILED—
Nov 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 26, 2022EX1GSOU EXTENSION 1 GRANTED—
Apr 26, 2022EXT1SOU EXTENSION 1 FILED—
Apr 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 12, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 22, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 25, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2021DOCKASSIGNED TO EXAMINER—
Dec 23, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance